Gujarat Kidney & Super Speciality Ltd Q1 FY2026-2027 Results: Summary

Revenue
₹34.98Cr
Net Profits
₹5.18Cr
Net Profit Margins
14.81%
Highlights
Revenue:

Gujarat Kidney & Super Speciality Ltd’s revenue jumped 129.08% since last year same period to ₹34.98Cr in the Q1 2026-2027. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated 11.79% jump in its revenue since last 3-months.

Net Profits:

Gujarat Kidney & Super Speciality Ltd’s net profit jumped 7.02% since last year same period to ₹5.18Cr in the Q1 2026-2027. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated 2.78% jump in its net profits since last 3-months.

Net Profit Margins:

Gujarat Kidney & Super Speciality Ltd’s net profit margin fell -53.28% since last year same period to 14.81% in the Q1 2026-2027. On a quarterly growth basis, Gujarat Kidney & Super Speciality Ltd has generated -8.06% fall in its net profit margins since last 3-months.

FAQs

What was the revenue for Gujarat Kidney & Super Speciality Ltd in Q1 results 2026?

The revenue for Gujarat Kidney & Super Speciality Ltd in the Q1 results 2026 was ₹34.98Cr.

What was the net profit for Gujarat Kidney & Super Speciality Ltd in Q1 results 2026?

The net profit for Gujarat Kidney & Super Speciality Ltd in the Q1 results 2026 was ₹5.18Cr.

What was the net profit margin for Gujarat Kidney & Super Speciality Ltd in Q1 results 2026?

The net profit margin for Gujarat Kidney & Super Speciality Ltd in the Q1 results 2026 was 14.81%.

What was the revenue for Gujarat Kidney & Super Speciality Ltd in Q1 results 2025?

The revenue for Gujarat Kidney & Super Speciality Ltd in the Q1 results 2025 was ₹15.27Cr.

What was the net profit for Gujarat Kidney & Super Speciality Ltd in Q1 results 2025?

The net profit for Gujarat Kidney & Super Speciality Ltd in the Q1 results 2025 was ₹4.84Cr.

What was the net profit margin for Gujarat Kidney & Super Speciality Ltd in Q1 results 2025?

The net profit margin for Gujarat Kidney & Super Speciality Ltd in the Q1 results 2025 was 31.70%.